Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03289039 |
|---|---|
| Brief Title: | Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer |
| First Submitted : | September 18, 2017 |
| First Submitted that Met QC Criteria : | September 18, 2017 |
| First Posted : | September 20, 2017 |
| Results First Submitted : | November 15, 2022 |
| Results First Posted with QC Comments : | December 12, 2022 |
| Results First Submitted that Met QC Criteria : | March 17, 2023 |
| Results First Posted : | March 21, 2023 |
| Last Update Submitted that Met QC Criteria : | February 9, 2024 |
| Last Update Posted : | February 13, 2024 |